REDWOOD SHORES, Calif., Dec. 9,
2019 /PRNewswire/ -- Clinical trials are an essential
gateway for getting new cures to market. However, many patients
struggle to find the right trials that meet their unique medical
requirements. To explore better ways to match patients with the
right trials, Oracle Health Sciences is once again participating
in The Opportunity Project (TOP) Technology Sprint: Creating
the Future of Health.
This year's entry joins Oracle technology with de-identified
precision oncology open data sets from the United States Department
of Veterans Affairs and the National Cancer Institute. The demo
will highlight how Artificial Intelligence (AI) and customer
experience solutions could be used to connect cancer patients with
available clinical trials and experimental therapies.
"It is paramount that we collaborate with our peers within the
federal government and technology communities to collectively
evaluate what innovative opportunities exist and to explore the
potential applications AI and machine learning can offer to fight
deadly diseases such as cancer," said Steve
Rosenberg, senior vice president and general manager, Oracle
Health Sciences. "The opportunity to participate in the TOP
challenge lets us apply Oracle solutions in new ways while also
harnessing the learnings to benefit the lives of patients who need
treatment in the future."
Connecting Patients with Critical Trials
This year Oracle's entry builds on the last technology sprint by
leveraging open datasets to explore more deeply the applications of
machine learning (ML) and AI. In addition, it demonstrates how
features for prospective trial recruitment will work with
appropriate identity protection.
Oracle's submission uses a combination of Oracle Healthcare
Foundation, Oracle CX Service, Oracle Policy
Automation, Oracle Digital Assistant and Oracle Graph Machine
Learning solutions to create a demonstration that in the future
might enable connecting patients and clinical staff through
intuitive interfaces that provide data at the point of care. A
graphical interface would allow physicians to track a patient's
care journey and would indicate which clinical trial options are
available. It applies AI to standardize data from clinical trial
requirement forms to specify eligibility criteria. The result can
be a more simplified and personalized experience to help determine
the best treatment for patients. Patients can also keep their
identifying information from being shared, while allowing only
their de-identified clinical data to be made available so they can
receive information about new programs, clinical studies or
therapies that may be of value to their care.
TOP is a 12-week technology development sprint that brings
together technology developers, communities, and government to
solve real-world problems using open data. TOP will host its Demo
Day 2019 on December 10, 2019 at the
U.S. Census Bureau in Suitland,
MD.
About Oracle Health Sciences
Oracle Health Sciences
breaks down barriers and opens new pathways to unify people and
processes to bring new drugs to market faster. As a leader in Life
Sciences technology, Oracle Health Sciences is trusted by 30 of the
top 30 pharma, 10 of the top 10 biotech and 10 of the top 10 CROs
for managing clinical trials and pharmacovigilance around the
globe.
About Oracle
The Oracle Cloud offers a
complete suite of integrated applications for Sales,
Service, Marketing, Human Resources, Finance, Supply Chain and
Manufacturing, plus Highly Automated and Secure Generation 2
Infrastructure featuring the Oracle Autonomous Database. For
more information about Oracle (NYSE: ORCL), please visit us
at oracle.com.
Trademarks
Oracle and Java are registered trademarks
of Oracle and/or its affiliates. Other names may be trademarks of
their respective owners.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/oracle-health-sciences-participates-in-top-tech-sprint-300970928.html
SOURCE Oracle